Your browser doesn't support javascript.
loading
Clinical Exposure Boost Predictions by Integrating Cytochrome P450 3A4-Humanized Mouse Studies With PBPK Modeling.
Zhang, Jin; Heimbach, Tycho; Scheer, Nico; Barve, Avantika; Li, Wenkui; Lin, Wen; He, Handan.
Afiliação
  • Zhang J; Drug Metabolism & Pharmacokinetics Department, Novartis Institutes for Biomedical Research, East Hanover, New Jersey 07936.
  • Heimbach T; Drug Metabolism & Pharmacokinetics Department, Novartis Institutes for Biomedical Research, East Hanover, New Jersey 07936.
  • Scheer N; Business Development Department, CEVEC Pharmaceuticals GmbH, Cologne 51105, Germany.
  • Barve A; Drug Metabolism & Pharmacokinetics Department, Novartis Institutes for Biomedical Research, East Hanover, New Jersey 07936.
  • Li W; Drug Metabolism & Pharmacokinetics Department, Novartis Institutes for Biomedical Research, East Hanover, New Jersey 07936.
  • Lin W; Drug Metabolism & Pharmacokinetics Department, Novartis Institutes for Biomedical Research, East Hanover, New Jersey 07936.
  • He H; Drug Metabolism & Pharmacokinetics Department, Novartis Institutes for Biomedical Research, East Hanover, New Jersey 07936. Electronic address: handan.he@novartis.com.
J Pharm Sci ; 105(4): 1398-404, 2016 Apr.
Article em En | MEDLINE | ID: mdl-27019957

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Anti-HIV / Citocromo P-450 CYP3A Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male Idioma: En Revista: J Pharm Sci Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Anti-HIV / Citocromo P-450 CYP3A Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male Idioma: En Revista: J Pharm Sci Ano de publicação: 2016 Tipo de documento: Article